Novel macrocyclic inhibitors of hepatitis c virus replication

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/407 (2006.01) A61P 31/12 (2006.01) C08H 1/00 (2006.01)

Patent

CA 2686138

The embodiments provide macrocyclic compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Les modes de réalisation de la présente invention concernent des composés de formule générale (I), ainsi que des compositions, y compris des compositions pharmaceutiques, comprenant un composé sujet de l'invention. Les modes de réalisation concernent en outre des procédés de traitement, y compris des procédés de traitement d'une infection par le virus de l'hépatite C et des procédés de traitement d'une fibrose hépatique, lesdits procédés comprenant généralement l'administration à un individu qui en a besoin d'une quantité efficace d'une composition ou d'un composé sujet de l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel macrocyclic inhibitors of hepatitis c virus replication does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel macrocyclic inhibitors of hepatitis c virus replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel macrocyclic inhibitors of hepatitis c virus replication will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1984707

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.